Diagnosis of Tuberculosis Infection in Health Care Workers Using Ex-vivo Interferon-gamma Assay
Information source: Samsung Medical Center
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Latent Tuberculosis Infection
Intervention: 1-step tuberculin skin test (TST) and blood sampling (Other)
Phase: N/A
Status: Completed
Sponsored by: Samsung Medical Center Official(s) and/or principal investigator(s): Won-Jung Koh, M.D., Principal Investigator, Affiliation: Samsung Medical Center
Summary
The present study was to evaluate the usefulness of a whole-blood interferon-r release
assays (IGRAs) as diagnostic tool of the latent tuberculosis infection for healthcare
workers.
Clinical Details
Official title: Diagnosis of Tuberculosis Infection in Health Care Workers Using Ex-vivo Interferon-gamma Assay
Study design: Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening
Primary outcome: Annual Incidence of Tuberculosis Infection Among Newly Employed Doctors and Nurses in Korea
Secondary outcome: Negative Conversion Rate in Follow-up QuantiFERON-TB Gold In-Tube Test (QFT-IT Test) After Treatment of Latent Tuberculosis Infection (LTBI)
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- doctors and nurses newly hired at Samsung Medical Center between February, 2008 and
November, 2008.
Exclusion Criteria:
- Non-applicable
Locations and Contacts
Samsung Medical Center, Seoul 135-710, Korea, Republic of
Additional Information
Starting date: January 2008
Last updated: December 6, 2011
|